Sanofi India Limited (SIL) announced the elevation of N. Rajaram as the Managing Director of the Company, with effect from 1st January, 2018. His appointment was approved by the Sanofi India Board of Directors earlier today. N. Rajaram joined Sanofi India in February 2014 and was appointed as Whole Time Director in October 2015. Under his leadership, the Company has doubled the size of its diabetes business and established a foothold in the consumer healthcare sector, while significantly transforming its market operations.
Rajaram brings with him diverse experience of nearly two decades in the FMCG industry with Hindustan Unilever, and in the telecom industry with Airtel. Rajaram holds a bachelor’s degree in Engineering from the Birla Institute of Technology & Science (BITS), Pilani, India and an MBA in International Business from the Indian Institute of Foreign Trade (IIFT), New Delhi. He is also an alumnus of the Advanced Managed Program of the Harvard Business School.
Rajaram succeeds Dr. Shailesh Ayyangar who has been the Managing Director of Sanofi India Limited for over 12 years. Dr. Ayyangar will take up a new role in the Sanofi Asia region effective January 1st, 2018. He will also continue as a Non-Executive Director on the Board of Sanofi India Limited.
Speaking about the transition, Dr. Ayyangar said, “I am truly grateful for the trust and confidence reposed on me over the years, by Sanofi India Limited’s shareholders, and other stakeholders including our employees and the senior leadership within Sanofi. It has been a real privilege to serve the Company and the country over a long period.” He further added that “While I am looking forward to taking on a new position in Sanofi Asia region, I am delighted to welcome N. Rajaram as the new Managing Director of SIL. This transition has been planned well in advance and I am very confident that under his leadership, SIL will scale greater heights of performance and continue to serve the patients of our country”.
Speaking on the occasion, N. Rajaram said, “Sanofi is a great global organization, which is focused on delivering transformational outcomes for patients based on scientific innovation and improved access to healthcare solutions. Our people have a contagious commitment and passion to empower the lives of the millions of patients we serve, making Sanofi an exciting and purposeful place to work. I’m thrilled to be part of this journey and hope to steer the Company through its next phase of growth”.